CALCiViS News

CALCiViS raises £3.15 million to Fund PMA Approval of the CALCIVIS® Imaging System ahead of a Planned US Launch in 2019

Edinburgh, August 2nd 2018 - CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces it has closed a £3.15 million equity funding round from existing investors Archangel Investors, Julz and the Scottish Investment Bank. The proceeds will be used to...

CALCiViS To Attend The IADR/PER General Session In London, England

Join us at the 96th General Session and Exhibition of the International Association of Dental Research IADR/PAN European Regional Congress ENABLING PREVENTIVE DENTISTRY – BIOTECHNOLOGY BASED IMAGING Thursday, 26 July 2018 11.30h to 13.00h This program will discuss modern cariology and the paradigm shift to minimally invasive and preventive dentistry...

CALCiViS launches its unique CALCIVIS imaging system in the United Kingdom

CALCiViS , a medical devices company focused on revolutionising the management of tooth decay, today announces the first commercial launch of its unique CALCiViS imaging system in the United Kingdom (UK). The CALCiViS imaging system is a sophisticated medical device and consumable combination designed to transform the assessment and management...

CALCiViS announces FDA filing of the Pre-Market Approval (PMA) application for its unique CALCIVIS imaging system

Edinburgh, November 2017 – CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces that the FDA has accepted its CALCiViS imaging system Pre-Market Approval (PMA) Application for substantive review. The filing of the PMA application to the FDA was made...

CALCiViS announces positive results from PMA clinical study evaluating its unique CALCIVIS® imaging system

Edinburgh, 1 November 2017 – CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces positive results from its pivotal Premarket Approval (PMA) clinical study evaluating its unique CALCiViS imaging system in the assessment of active dental demineralisation. The successful study...

CALCiViS launches new video

What do jellyfish have in common with dental caries? CALCiViS has released a brand new video to illustrate how its innovative technology works – access it at https://vimeo.com/238365978 This video demonstrates how bioluminescence (light-emission) seen in nature, including in marine life such as jellyfish, is now utilised in dentistry to...

CALCiViS closes equity funding to advance imaging system

  Proceeds will be used to file a PMA with FDA and to launch the imaging system in the UK Edinburgh, October 4th 2017 - CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces it has secured new equity funding. ...

CALCiViS to present at the 5th Annual MedTech & Digital Health Forum in Basel, Switzerland

Edinburgh, 22 September 2017 – CALCIVIS, a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces that its Chief Executive Officer (CEO) Adam Christie will present at the Sachs 5th Annual MedTech & Digital Health Forum on 25 September 2017 at 10:45am CET...

CALCiViS presents imaging system to Parliament

July 12th 2017. CALCiViS imaging system developer and Chief Technical Officer, Bruce Vernon, presents the CALCiViS imaging system to an All Parliamentary Group for Dental innovation as part of the British Dental Industry Associations  "innovation in Dentistry" group. Link to images The session, jointly organised by the British Dental Industry Association...

CALCiViS presents new clinical evidence to International Research Association

July 5th to 8th 2017 - CALCiViS presents five new clinical publications at the 64th International Organisation for Caries Research (ORCA) meeting in Oslo, Norway.   The publications focus entirely on the revolutionary CALCiViS photoprotein and its unique ability to help determine early enamel demineralisation - at a stage when...
Web Design by: Purple Imp